Our Management – BOD

 

Sr no.

Board of Directors

Designation

1

Dr. Naresh Trehan

Chairman & Managing Director

2

  Mr. Pankaj Prakash Sahni  

Group CEO & Director

3

Mr. Hari Shanker Bhartia

Non-Executive Independent Director

4

Ms. Praveen Mahajan

Non-Executive Independent Director

5

Mr. Rajan Bharti Mittal

Non-Executive Independent Director

6

Dr. Ravi Gupta

Non-Executive Independent Director

7

Mr. Ravi Kant Jaipuria

Non-Executive Nominee Director

8

Mr. Sunil Sachdeva

Non-Executive Director

9

Mr. Venkatesh R.

Non-Executive Nominee Director

10

Mr. Vikram Singh Mehta

Non-Executive Independent Director

Quarterly Financial Results

Shareholders’ Notices

Media Arrangement

General Meetings

Postal Ballot

Standalone

Consolidated

RPT

Credit Rating

Following is the list of credit ratings obtained by the Company from CRISIL.

 

Total Bank Loan Facilities Rated

Rs. 500 Crore

Short Term Rating

CRISIL A1+ (Reaffirmed)

Long Term Rating

CRISIL A+ (Reaffirmed)

 

  • CRISIL Report 
CRISIL Report -19.09.2022 Click here

Secretarial Audit

Contact Details

Registered Office:
Medanta-Mediclinic E-18,
Defence Colony
New Delhi-110024
Ph No.011- 44114411

Corporate Office:
Medanta – The Medicity,
Sector-31, Gurugram,
122001, Haryana
Phno: 124-414 1414

For Investor Grievances
Mr. Rahul Ranjan, Compliance Officer
Medanta – The Medicity,
Sector-31, Gurugram,122001, Haryana
Tel: 124 483 4060;
Email: : compliance@medanta.org

Registrar & Share Transfer Agent
KFin Technologies Private Limited
Selenium, Tower-B
Plot 31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareddi 500 032
Telangana, India
Tel: +91 40 6716 2222

E-mail: globalhealth.ipo@kfintech.com
Investor grievance e-mail: einward.ris@kfintech.com
Website: www.kfintech.com
SEBI Registration No.: INR000000221

 

Contact Details of Key Managerial Personnel Under Regulation 30(5) of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015

 

S. NoName & DesignationEmail addressContact Number 
1. 

Dr. Naresh Trehan,

Chairman & Managing Director

Naresh.Trehan@Medanta.org Tel: +91 124 483 4060
2. 

Mr. Pankaj Sahni,

Group Chief Executive Officer

Pankaj.Sahni@Medanta.org

 

 

Composition of Committee

 

Audit Committee

Sr no.

Name of the Members

Designation 

1

Mr. Ravi Gupta, Independent Director

Chairman

2

Ms. Praveen Mahajan, Independent Director

Member

3

Mr. Venkatesh Ratnasami, Non-Executive Director

Member

 

Nomination and Remuneration Committee

Sr no.

Name of Committee Members

Category

1

Mr. Vikram Mehta, Independent Director

Chairperson

2

Ms. Praveen Mahajan, Independent Director

Member

3

Mr. Rajan Bharti Mittal, Independent Director

Member

4

Dr. Naresh Trehan, Chairman & Managing Director

Member

 

Corporate Social Responsibility Committee

Sr no.

Name of Committee Members

Category

1

Dr. Naresh Trehan, Chairman & Managing Director

Chairperson

2

Mr. Sunil Sachdeva, Non-Executive Director

Member

3

Mr. Rajan Bharti Mittal, Independent Director

Member

4

Mr. Vikram Singh Mehta, Independent Director

Member

 

Risk Management Committee

Sr no.

Name of Committee Members

Category

1

Dr. Ravi Gupta, Independent Director

Chairperson

2

Ms. Praveen Mahajan, Independent Director

Member

3

Mr. Pankaj Sahni, CEO

Member

 

Stakeholders Relationship Committee

Sr no.

Name of Committee Members

Category

1

Dr. Ravi Gupta, Independent Director

Chairperson

2

Mr.  Ravi Jaipuria, Non-Executive Director

Member

3

Mr. Rajan Bharti Mittal, Independent Director

Member

4

Mr. Hari Shanker Bhartia, Independent Director

Member

IPO Documents

Material Documents

B.1_CTC of MOA & AOA

B.2_COI_13.08.2004

B.3_Fresh COI dated 11.08.2021

B.4_BR_Authorising Offer_17.09.2021

B.5_Shareholder Resolution_Authorising Offer_21.09.2021

B.6_BR Approving DRHP_29.09.2021

B.7_BR Approving Addendum to DRHP

B.8_BR and Shareholders Approval for Modification in OFS

B.9_BR_RHP Approval_22.10.2022

B.10_CTC- Prospectus Approval-November 9 2022

B.11_Consent Letter of Investor Selling Shareholder_11 10 2021

B.12 Share Purchase Agreement_13052017

B.13_Scheme of amalgamation and merger of NTAHS with Co

B.14_SHA _29 10 2013

B.15_SHA _12 01 2015

B.16_RJ Corp_ Investment Agreeement_Suppl Agreement and Undertaking

B.17_Agreement dated 13 05 2017_ Dr NT and SS

B.18_ WATA

B.19_Agreement for CCPS Conversion_04.01.2022

B.20_Trademark License Agreement Amendment Agreements and Waiver Letters

B.21_Resolutions for appoinment of Dr NT as CMD

B.22_Resolutions for appoinmnet of Dr NT as Chaiman-Heart Institute and CCS

B.23_ BR dated July 25 2022 _Re appoinment of Dr NT as CMD

B.24_Annual Report 19-20

B.24_Annual Report 20 21

B.24_Annual Report 21-22

B.25_CA Examniation Report_02 09 22

B.26_Special tax Benefit Report_14 10 2022 (1)

B.27_Assessment of of the healthcare delivery market in India _26 09 2022

B.28_Consent for Assessment of Health Delivery Market_26 09 2022_CRSIL

B.29_Engagement Letter of CRISIl_15 09 22

B.30_Consents_76

B.31_Consent of CA to Include their name

B.32_Consent of RM Marwah CA to Include their name

B.33_Triparty Agreement btw Co CDSl Registrar_09 09 2021

B.34_Triparty Agreement btw Co NSDl Registrar_09 04 2021

B.35_DD Certificate_29 09 2021

B.36_In Principle Approval_21 10 21 and 22 10 21

B.37_Final Observation Letter_21 12 21

Details Of Familiarization Programmes Imparted To Independent Directors

Details Of Agreements Entered Into With The Media Companies

Statement of Deviations or variations as specified under Reg. 32

General Meeting and Postal Ballot Notices

Secretarial Compliance Report Under Reg. 24(A)

Feedback